Background: Beta-secretase 1 (BACE1) is attracting increasing attention for its vital role in pathogenesis of many neuropsychiatric disorders and many studies also have indicated BACE1 as a possible risk factor for seizures, but not any studies have reported association between BACE1 gene polymorphisms and seizures. Therefore, we investigated the possible association between focal seizures and BACE1 gene polymorphisms in the present study.
Introduction
Epilepsy is a chronic episode of noncommunicable disorder in the brain due to abnormal excessive or synchronous neuronal activity and it affects about 70 million people worldwide, [1] accounting for approximately 1% of the population currently. [2, 3] It is reported that 1 epilepsy patient may affected about 4 normal people at some point in time. [4] Focal seizures (also called partial seizures) are one of the most common types of epilepsy and are characterized by affecting initially only one hemisphere of the brain. It can be split into 2 main categories: simple partial seizures and complex partial seizures. The symptoms of the focal seizures will vary on the base of where the seizure occurs. [5, 6] Beta-secretase 1 (BACE1) is an enzyme encoded by the BACE1 gene in human and also known as beta-site amyloid precursor protein cleaving enzyme 1. [7] It is important in the formation of myelin sheaths in peripheral nerve cells. [8] It is widely accepted that BACE1 cleaves amyloid precursor protein (APP) at the N-terminal end of the b-amyloid peptide (Ab) and is identified as the Alzheimer's b-secretase. [9, 10] It has been validated that some of the BACE1 substrates may conducive to the synaptic deficits seen with BACE blockade, including the seizure-related gene 6. [11] Seizures is also associated with BACE1, since that the patients displaying seizures symptom show earlier onset of cognitive decline and faster transition into severe dementia. [12, 13] Additionally 2 groups have reported that BACE1 knockout mice develop epileptic seizures. [14, 15] Moreover, BACE1 can hydrolyze the neuregulin (NRG1), which show antiepilepsy effect [8] and one of our previous studies indicate that the SNP of NGR1 is associated with the seizures susceptibility. [16] Based on these findings, we speculate that the gene polymorphisms of the BACE1 may increase the risk of seizure onset. The rs535860, rs525493, and rs638405 were the most studied BACE1 gene polymorphisms and showed potential effect of different alleles, the coding position of which are c.
* 404T>A, c.261+3543A>C, and c.579G>C, respectively, located in Chromosome11. The aim of this present study was to investigate the role of BACE1 (rs535860, rs525493, rs638405) gene polymorphisms in Chinese focal seizures population, which were indeed more widely investigated in Caucasians but less explored among Chinese Han population, which constitutes approximately 92% of the population of China and is the nationality with the largest population in the world. and reverse 5 0 -TCCTTGCAGTCCATTTTCAG -3 0 . A DNA sequencer was applied to detect the amplified products. More than 10% of the samples were randomly selected and retested to verify the validity of this procedure, and the results of the retested samples were consistent with those obtained from the original sample.
Materials and methods

Subjects
Statistical analysis
All genotyping results in focal seizures patients and in controls were tested for Hardy-Weinberg Equilibrium (HWE) by applying Chi-square test (x 2 test). Differences in genotype distributions and allele frequencies in cases and controls were compared between groups for statistical significance by Chisquare statistics (x 2 test). The associations between the genotypes and the focal seizures were evaluated via the odds ratio (OR), with a 95% confidence interval (CI) (95% CI). A two-sided P value below .05 was considered statistically significant. All statistical analyses were performed with SPSS 17.0 for Windows (SPSS Inc., Chicago, IL).
Results
The observed BACE1 (rs535860, rs525493, rs638405) genotype frequencies were in accordance with the Hardy-Weinberg equilibrium in both study groups. We then analyzed the allele and genotype frequencies of the BACE1 SNP in 162 focal seizures patients and 211 controls. The distributions of BACE1 rs535860 (A>T), rs525493 (G>T), rs638405 (C>G) SNP restriction site genotypes in the focal seizures patients and the controls are presented in Table 1 . It was observed that there was no Table 1 Genotypic and allelic distribution of the BACE1 gene between all patients (n = 162) and controls (n = 211). Yang et al. 97: 13 Medicine statistically significant difference between patients and controls for the genotype and allele distributions of rs525493 (G>T) and rs638405(C>G) polymorphisms. However, the frequency of rs535860 genotype with AT was significantly higher among the focal seizures patients relative to the controls (OR = 1.836, 95% CI = 1.086-3.102, P = .023). Moreover, the genotype of AT+TT for rs535860 showed a significant association with focal seizures group (OR = 1.769, 95% CI = 1.056-2.961, P = .030) while there was no significant difference in allele frequency of BACE1 rs535860 (A>T). It was interesting that the statistically significant difference of BACE1 rs535860 genotype only existed among males (OR = 2.727, 95% CI = 1.273-5.845, P = .010 for AA vs AT; OR = 2.435, 95% CI = 1.177-5.039, P = .016 for AA vs AT + TT; Table 2 ) while there was no statistically significant difference among females (OR = 1.241, 95% CI = 0.583-2.640, P = .576 for AA vs AT, Table 3 ). Additional, the rs535860 allele frequency also existed a statistically difference among males (OR = 2.000, 95% CI = 1.036-3.860, P = .039 for A vs T; Table 2 ).
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Discussion
Alzheimer's disease (AD) is a common age-related and devastating neurodegenerative disorder involving a decline in memory Table 2 Genotypic and allelic distribution of the BACE1 gene between male patients (n = 91) and controls (n = 104). CI = confidence interval, OR = odds ratio. * P value for genotype and allele frequencies in cases and controls using 2-sided x 2 test. † P values adjusted by age and gender using logistic regression. * * P < .05.
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Table 3
Genotypic and allelic distribution of the BACE1 gene between female patients (n = 71) and controls (n = 107). CI = confidence interval, OR = odds ratio. * P value for genotype and allele frequencies in cases and controls using 2-sided x 2 test. † P values adjusted by age and gender using logistic regression.
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presenting symptoms. AD and epilepsy show numerous similar pathological features including temporal lobe atrophy, neuronal death, gliosis, neuritic alterations, and inflammation. The human and animal studies had proved that there exists a link between AD and seizures or epileptiform neuronal activity [17, 18] and the incidence for the seizures increased in individuals with AD-type dementia, especially in early onset cases. [19] BACE1 has become infamous for playing a critical role in the pathogenesis of Alzheimer's disease and is the key rate-limiting enzyme for the genesis of amyloid-b (Ab) peptides, the main constituents of the amyloid plaques in the brains of AD patients. Given that the relationship between AD and seizures and the key function of BACE1 at AD, we explored the relevance between BACE1 gene polymorphism and focal seizures in a Chinese Han population for the first time.
The Sez6 gene is a highly conserved gene in both mice and humans, and it has been proved that the mutations and/or altered expression of sez6 are associated with seizures. [11, 20] Its 3 family members, Sez6, Sez6-like (Sez6L), and Sez6-like 2 (Sez6L2), were identified as BACE1 substrates [18] and Sez6 is a prime candidate for involvement in the synaptic dysfunction seen with BACE inhibition. [17] Thus, there exists a possibility that the BACE1 gene polymorphism may affect the development of seizures.
NRG1 is one of the epidermal growth factor (EGF)-like proteins and has a series of physiological functions in the peripheral and central nervous systems, such as myelination, remyelination, synaptic plasticity, and maintenance of muscle spindles. NRG1 is a substrate of BACE1, which is critical for NRG1's cleavage and can affect its biological functions. Our previous study had proved that there is an association between NRG1 (rs35753505) gene polymorphisms and temporal lobe epilepsy. Considering the close relation between BACE1 and NRG1, we further studied effect of the BACE1 gene polymorphisms on the focal seizures.
In addition to be able to affect the brain by cleavage of APP and proteolysis, BACE1 can act on ion channels, which has also been identified as epilepsy genes. [19] Voltage-gated sodium channels (Na v ) were the first ion channels to be identified as targets of BACE1. [21] In 2010, BACE1 cleavage sites were mapped in the b2 subunit of Na v. [22] In support of the involvement of BACE1 in epilepsy, some researchers found that neurons from BACE1-deficient mice have lower levels of Na v compared to their wild type counterparts. It has been proved that the mutations in both a-or b-subunits were associated with epilepsy. [23] Voltage-gated potassium channel was another prominent channel affected by BACE1, especially the KCNQ family, KCNQ2 and KCNQ3 of which are the principal components of neuronal M-current. [24] KCNQ2 and KCNQ3 mutations can emphasize the vital role of Mcurrent in keeping the balance between excitation and inhibition of neuronal and can result in an infantile epilepsy syndrome. [25] The epidemiology of epilepsy in humans indicates that the prevalence of epilepsy is slightly higher in males compared to females. [26] One of the striking results of this research is that there exists difference between male patients and controls on the genotype frequency of rs535860, while no difference between female patients and controls was found, which was in accordance with the gender difference of epilepsy occurrence. rs535860 located in BACE1 3 0 UTR (untranslated region), which were minor allele count T = 0.1096/549 (for T) and Ref SNP Alleles A/ T, showing conserved functional role throughout the evolution. One study showed that BACE1 miRNA genetic variability has no major role in risk for Alzheimer disease, while the authors did observe the statistical interaction between rs535860 and the near miR29a rs34772568. Combining with our research results, the rs535860 may play important function on nervous system disease. [27] In addition, in line with our findings, in one study using transgenic mice that conditionally express dominantnegative KCNQ2 subunits in brain, Peters et al [28] found that most male mutants showed frequent 'stargazer'-like dorsal head and neck extensions, which were likely indicative of partial seizures, but no spontaneous seizure activity was observed in any of the female mutants.
Conclusion
In summary, as far as we know, this is the first report that provides a potential link between the BACE1 polymorphism (rs535860) and focal seizures in a Chinese Han population. These results may inspire new evidence of seizures and should promote replication studies in ethnically disparate populations in cohort study samples and with variants covering the whole gene. However, considering the present study is limited by the relative small sample size, these findings need to be consolidated by further studies involving more ethnics and a larger group of patients.
